Register for the 23rd CCG VIP Luncheon: China’s Healthcare in the Post-Pandemic Era
Join George F. Gao and Yanzhong Huang for a curated luncheon discussion with two leading experts on China’s healthcare system and global health governance.
Venue: Beijing (exact location to be shared upon successful registration)
Dress Code: Business
China is entering a new phase of healthcare expansion, with continued efforts to increase universal coverage, improve system efficiency, and support industry upgrading. These changes carry significant implications for domestic and multinational stakeholders alike.
During the 15th Five-Year Plan period, Beijing aims to raise China’s average life expectancy to 80 years old, steadily moving towards a higher goal. These developments and changes are not only related to the health and well-being of the Chinese people, but also bring new development opportunities and challenges to relevant market entities.
This session will examine the trajectory of China’s healthcare reform and the development of the health and wellness sector, with particular attention to policy direction, industry trends, international dimensions, and Chinese-U.S. role in global health governance.
Key Speakers
George F. Gao
Academician of the Chinese Academy of Sciences; Former Director of the Chinese Center for Disease Control and Prevention (CDC)
Gao is a leading expert in virology and public health, with extensive experience in China’s research and healthcare governance system, including at its unprecedented juncture.
Yanzhong Huang
Senior Fellow for Global Health at the Council on Foreign Relations (CFR), Professor at Seton Hall University
Huang has testified before U.S. congressional committees multiple times and is regularly consulted by major media outlets, the private sector, and governmental and nongovernmental organizations on global health issues and China. He is a life member of the Council on Foreign Relations. His expertise includes Chinese health politics, global health security, and US-China relations.
Discussion topics include:
Policy priorities and direction in China’s healthcare system
Trends shaping the health and wellness sector
Innovation and commercialization in biomedicine, including implications for pharmacetuical companies
China’s role in global health governance
Format:
The two speakers will each deliver a short presentation, followed by a panel discussion moderated joined by Henry Huiyao Wang, founder and president of CCG. The session will conclude with an in-depth, interactive Q&A with guests.
